ERBB2 and neoplasm: In keeping with known aggressiveness based on molecular subtype [2,3,4,37], with luminal being the least aggressive, basal the most aggressive and HER2-enriched in between, SUVmax, MTV and TLG of the primary tumour were highest in basal, followed by HER2-enriched and least in the luminal subtype.